ES478806A1 - Un metodo de preparacion de eritrocitos c3-c4-sensibilizados. - Google Patents

Un metodo de preparacion de eritrocitos c3-c4-sensibilizados.

Info

Publication number
ES478806A1
ES478806A1 ES478806A ES478806A ES478806A1 ES 478806 A1 ES478806 A1 ES 478806A1 ES 478806 A ES478806 A ES 478806A ES 478806 A ES478806 A ES 478806A ES 478806 A1 ES478806 A1 ES 478806A1
Authority
ES
Spain
Prior art keywords
cells
sensitized
igg
igm
erythrocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478806A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Hospital Supply Corp
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of ES478806A1 publication Critical patent/ES478806A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Un surtido de cuatro suspensiones celulares que contiene eritrocitos mono-específicamente sensibilizados con IgG, Img, C3 y C4. Las suspensiones proporcionan células de control para determinar la pureza y concentración de los anticuerpos a estas inmunoglobulina o componentes complementarios contenidos en antisueros utilizados para ensayos clínicos. Un estricto control del pH, temperatura y concentración de EDTA de una solución a la que se agrega sangre permite la producción selectiva de células C3 o C4 sensibilizadas. La selección de un suero con anticuerpos IgG o IgM y la inactivación de las proteínas indeseadas permite la producción de células IgG o igM sensibilizadas. Las células resultantes tienen un poder de reacción de aglutinación de 2-4+ aproximadamente, Los eritrocitos del hombre y de otros animales pueden experimentar la sensibilización mono-específica. Otras proteínas humanas, como IgA o C5 , y proteínas de plasma de otros animales pueden ser análogamente combinadas mono-específicamente a los glóbulos rojos de la sangre
ES478806A 1978-03-20 1979-03-20 Un metodo de preparacion de eritrocitos c3-c4-sensibilizados. Expired ES478806A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/890,558 US4247536A (en) 1978-03-20 1978-03-20 Method of preparing C3-sensitized erythrocytes

Publications (1)

Publication Number Publication Date
ES478806A1 true ES478806A1 (es) 1979-12-01

Family

ID=25396832

Family Applications (1)

Application Number Title Priority Date Filing Date
ES478806A Expired ES478806A1 (es) 1978-03-20 1979-03-20 Un metodo de preparacion de eritrocitos c3-c4-sensibilizados.

Country Status (5)

Country Link
US (1) US4247536A (es)
EP (1) EP0014214A4 (es)
CA (1) CA1114743A (es)
ES (1) ES478806A1 (es)
WO (1) WO1979000796A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980002459A1 (en) * 1979-04-30 1980-11-13 Immunology Dev Corp New and improved methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
EP0039195B1 (en) * 1980-04-28 1986-06-18 Montefiore Hospital and Medical Center Antibody detection process
US4375459A (en) * 1980-06-20 1983-03-01 The Regents Of The University Of California Cytoreceptor assay
US4693967A (en) * 1981-02-18 1987-09-15 Research Corporation Monitoring therapy results in body samples of receptor cells
FR2687788B1 (fr) * 1992-02-24 1994-12-30 Aetsrn Materiel pour la mise en evidence en phase solide, de complexes antigenes-anticorps par des hematies indicatrices sa methode de preparation et son utilisation.
FR2899337B1 (fr) * 2006-03-31 2008-07-04 Univ Reims Champagne Ardenne Standard c4d / c4b pour cytometrie de flux quantitative du rejet humoral de transplantation.
CN115267181A (zh) * 2022-07-26 2022-11-01 广州市第一人民医院（广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院） 一种用于冷凝集血常规标本检测的试剂及其检测方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
US4130634A (en) * 1974-03-15 1978-12-19 University Of Illinois Foundation Method for detecting and quantifying antigens
US4092114A (en) * 1976-10-20 1978-05-30 Fisher Scientific Company Indirect latex test for determination of immunoglobulins

Also Published As

Publication number Publication date
EP0014214A1 (en) 1980-08-20
EP0014214A4 (en) 1980-09-29
WO1979000796A1 (en) 1979-10-18
US4247536A (en) 1981-01-27
CA1114743A (en) 1981-12-22

Similar Documents

Publication Publication Date Title
Harboe et al. 23. Immunization, isolation of immunoglobulins, estimation of antibody titre
Førre et al. Evidence of similar idiotypic determinants on different rheumatoid factor populations
IE48400B1 (en) Process for immunologic determination tests
KR890701632A (ko) 사람 인터루킨-4에 대한 모노클로날 항체 및 이를 생성하는 하이브리도마
US4130634A (en) Method for detecting and quantifying antigens
Wiik et al. Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors
Chartrand et al. The Evolution of the Immune Response: XII. The Immunoglobulins of the Turtle. Molecular Requirements for Biologic Activity of 5.7 S Immunoglobulin
JPS60237363A (ja) 免疫グロブリンの定量方法
Rudich et al. Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies.
Bartosz et al. Aging of the erythrocyte XVII. Binding of autologous immunoglobulin G
Habibi et al. Auto‐anti‐Pra: a ‘second’example in a newborn
Lacey et al. Studies on the blood of a Co (a‐b‐) proposita and her family
Dobloug et al. Demonstration of rheumatoid factor idiotypic antigens on peripheral blood B and T lymphocytes from patients with rheumatoid arthritis
Pepys et al. Sepharose‐C3: I. Preparation and Use as an Immunosorbent
Cikes An improved quantitative micro-complement fixation test
Daniels,* et al. A monoclonal antibody related to the human blood group Gerbich
Langenscheidt et al. Quantitation of platelet antigens after chloroquine treatment
Nishioka et al. A binding activity of actin with human C1q
ES8106834A1 (es) Un metodo de producir un antisuero que tiene una mejor cua- lidad aglutinante
CA1287801C (en) Method for determining human collagen peptides by way of enzyme immunoassay
Thorpe Detection of Rh D‐associated epitopes in human and animal tissues using human monoclonal anti‐D antibodies
Goosen Isolation of subclasses of human IgG with affinity chromatography
Waller et al. Serological specificity of IgG and IgM antiglobulin antibodies in anti-Gm (a) antisera
Daniels et al. FURTHER ANALYSIS OF THE MONOCLONAL ANTIOBODY H8 DEMONSTRATING A JMH‐RELATED SPECIFICITY
Hancock et al. Detection of antibody-coated sperm by ‘panning’procedures